Slight increase of serum s-100B during porcine endotoxemic shock may indicate blood-brain barrier damage

Anesthesia and Analgesia

Volumn 101, Issue 5, 2005, Pages 1465-1469

  Larsson, Anders ^a   Lipcsey, Miklós ^a   Sjölin, Jan ^a   Hansson, Lars Olof ^a   Eriksson, Mats B ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; PROTEIN S100B;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN DISEASE; DISEASE MARKER; ENDOTOXEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAM NEGATIVE INFECTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEPTIC SHOCK; SWINE;

EID: 27444446602     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ANE.0000180193.29655.6A     Document Type: Article

References (29)

1. Moore BW. A soluble protein characteristic of the nervous system. Biochem Biophys Res Commun 1965;19:739-44.
2. Zimmer DB, Cornwall EH, Landar A, Song W. The S100 protein family: history, function, and expression. Brain Res Bull 1995;37:417-29.
3. Heizmann CW, Fritz G, Schafer BW. S100 proteins: structure, functions and pathology. Front Biosci 2002;7:1356-68.
4. Schafer BW, Wicki R, Englelkamp D, et al. Isolation of a YAC clone covering a cluster of nine S100 genes on human chromosome 1q21: rationale for a new nomenclature of the S100 calcium-binding protein family. Genomics 1995;25:638-43.
5. Takahashi K, Isobe T, Ohtsuki Y, et al. Immunohistochemical study on the distribution of alpha and beta subunits of S-100 protein in human neoplasm and normal tissues. Virchows Arch B Cell Pathol Incl Mol Pathol 1984;45:385-96.
6. Banfalvi T, Gilde K, Gergye M, et al. Use of serum 5-S-CD and S-100B protein levels to monitor the clinical course of malignant melanoma. Eur J Cancer 2003;39:164-9.
7. Mårtenson ED, Hansson LO, Nilsson B, et al. Serum S-100b protein as a prognostic marker in malignant cutaneous melanoma. J Clin Oncol 2001;19:824-31.
8. Hauschild A, Englel G, Brenner W, et al. S100B protein detection in serum is a significant prognostic factor in metastatic melanoma. Oncology 1999;56:338-44.
9. Wunderlich MT, Ebert AD, Kratz T, et al. Early neurobehavioral outcome after stroke is related to release of neurobiochemical markers of brain damage. Stroke 1999;30:1190-5.
10. Martens P, Raabe A, Johnsson P. Serum S-100 and neuron-specific enolase for prediction of regaining consciousness after global cerebral ischemia. Stroke 1998;29:2363-6.
11. Rosen H, Rosengren L, Herlitz J, Blomstrand C. Increased serum levels of the S-100 protein are associated with hypoxic brain damage after cardiac arrest. Stroke 1998;29:473-7.
12. Ingebrigtsen T, Romner B, Marup-Jensen S, et al. The clinical value of serum S-100 protein measurements in minor head injury: a Scandinavian multicentre study. Brain Inj 2000;14:1047-55.
13. Michetti F, Gazzolo D. S100B protein in biological fluids: a tool for perinatal medicine. Clin Chem 2002;48:2097-104.
14. Anderson RE, Hansson LO, Nilsson O, et al. High serum S100B levels for trauma patients without head injuries. Neurosurgery 2001;48:1255-8.
15. Ytrebo LM, Nedredal GI, Korvald C, et al. Renal elimination of protein S-100beta in pigs with acute encephalopathy. Scand J Clin Lab Invest 2001;61:217-25.
16. Ytrebo LM, Ingebrigtsen T, Nedredal GI, et al. Protein S-100beta: a biochemical marker for increased intracranial pressure in pigs with acute hepatic failure. Scand J Gastroenterol 2000;35:546-51.
17. Pokela M, Anttila V, Rimpilainen J, et al. Serum S-100beta protein predicts brain injury after hypothermic circulatory arrest in pigs. Scand Cardiovasc J 2000;34:570-4.
18. Krieter H, Denz C, Janke C, et al. Hypertonic-hyperoncotic solutions reduce the release of cardiac troponin I and s-100 after successful cardiopulmonary resuscitation in pigs. Anesth Analg 2002;95:1031-6.
19. Rosen H, Sunnerhagen KS, Herlitz J, et al. Serum levels of the brain-derived proteins S-100 and NSE predict long-term outcome after cardiac arrest. Resuscitation 2001;49:183-91.
20. Mussack T, Dvorak J, Graf-Baumann T, Jochum M. Serum S-100B protein levels in young amateur soccer players after controlled heading and normal exercise. Eur J Med Res 2003;8:457-64.
21. Burrell R. Human responses to bacterial endotoxin. Circ Shock 1994;43:137-53.
22. Hariri RJ, Ghajar JB, Bahramian K, et al. Alterations in intracranial pressure and cerebral blood volume in endotoxemia. Surg Gynecol Obstet 1993;176:155-66.
23. Mutschler D, Eriksson M, Wikström B, et al. Microdialysis-evaluated myocardial COX-mediated inflammation and early circulatory depression in porcine endotoxemia. Crit Care Med 2003;31:1780-5.
24. Santak B, Radermacher P, Adler J, et al. Effect of increased cardiac output on liver blood flow, oxygen exchange and metabolic rate during long-term endotoxin-induced shock in pigs. Br J Pharmacol 1998;124:1689-97.
25. Young GB, Bolton CF, Austin TW, et al. The encephalopathy associated with septic illness. Clin Invest Med 1990;13:297-304.
26. Vellucci SV, Parrott RF. Expression of mRNAs for vasopressin, oxytocin and corticotrophin releasing hormone in the hypothalamus, and of cyclooxygenases-1 and -2 in the cerebral vasculature, of endotoxin-challenged pigs. Neuropeptides 1998;32:439-46.
27. Green R, Scott LK, Minagar A, Conrad S. Sepsis associated encephalopathy (SAE): a review. Front Biosci 2004;9:1637-41.
28. Unden J, Christensson B, Bellner J, et al. Serum S100B levels in patients with cerebral and extracerebral infectious disease. Scand J Infect Dis 2004;36:10-3.
29. Censullo JL, Sebastian S. Pentobarbital sodium coma for refractory intracranial hypertension. J Neurosci Nurs 2003;35:252-62.